4月9日 - ** Lucid Diagnostics LUCD.O因股票募集计划在延时交易中下跌约25%至1.24美元
** PAVmed Inc PAVM.O位于纽约的商业阶段子公司宣布发行 (link) 股票，但未披露交易规模
** 已发行股票约 9 075 万股，公司市值约 1.5 亿美元
** 周三股价上涨 1.9%，收于 1.65 美元。2024 年股价为 82 美分
** Canaccord Genuity 是拟议发行的唯一簿记管理人
** Lucid Lucid 公司称，该公司专注于数百万胃食管反流病患者(胃食管反流病)， 这些患者也被称为慢性胃灼热，有患食管癌前病变和癌症的风险。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.